1. to determine the feasibility and acceptability of an e-supported lifestyle coaching program and2. to assess the effects of personalized lifestyle support in patients with insulin dependent type 2 diabetes mellitus immediately after 12 weeks and…
ID
Source
Brief title
Condition
- Glucose metabolism disorders (incl diabetes mellitus)
- Nephropathies
- Lifestyle issues
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Main study parameter/endpoint
• Feasibility and sustainability of the proposed healthy lifestyle behaviors,
measured with 24-hour recall dietary diary, plus validated self-report on
physical activity and stress management activities (Ornish 1998).
• Attractiveness of the eSupport Lifestyle Intervention, measured via patient
satisfaction and the Technology Acceptance Model (TAM; Szajna 1996) on weeks 4,
12, 50.
Secondary outcome
Secondary study parameters/endpoints
• Quality of Life (SF-8)
• Exercise capability (aerobic & resistance tests, see below)
• Fasting plasma glucose, fasting plasma insulin, HbA1C, total cholesterol, HDL
cholesterol and triglyceride levels
• Blood pressure, BMI, waist circumference
• Kidney function: MDRD
• Albuminuria: Albumin/Creatinin Ratio.
• Medication requirements (insulin, metformin, statins, antihypertensives)
• Pancreas, muscle and liver tissue function as reflected by OGTT based
multi-parameter diagnosis (weeks 0, 12, 50).
• Liver, pancreas, skeletal muscle, kidney and heart ectopic fat accumulation
(weeks 0, 12, 50).
• Cardiac function (systolic and diastolic function, pulse wave velocity)
(weeks 0, 12, 50).
a. Heart function:
i. Systolic function: stroke volume, ejection fraction, cardiac output, cardiac
index, peak ejection rate.
ii. Diastolic function: early peak filling rate (E), early deceleration peak (E
dec peak), atrial peak filling rate (A), E/A ratio, peak mitral annulus
longitudinal motion (Ea), MR estimate of LV filling pressure (E/Ea)
b. Heart dimensions: End diastolic volume, end-systolic volume, LV mass, LV
mass index, LVMI/EDVI, percentage scar tissue (weeks 0, 12, 50).
c. Aorta and carotid vessel wall imaging: total vessel wall area, average
vessel wall thickness, minimum vessel wall thickness, maximum vessel wall
thickness, vascular distensibility (weeks 0, 12, 50).
d. Body fat distribution: (weeks 0, 12, 50).
i. Adipose tissue distribution, visceral and subcutaneous fat volume
ii. Pancreatic fat content
iii. Epicardial fat volume
iv. 1H-MRS of the heart, skeletal muscle, liver and kidney triglyceride content
These measurements will be conducted at baseline, after 4 weeks, 12 weeks and
at 1 year follow up, with three exceptions: a) the extensive OGTT based
multi-parameter diagnosis will not be conducted at week 4; b) for patient
satisfaction and eSupport attractiveness (TAM) the first measurement is
conducted at week 4; c) MR assessment will be performed at baseline, week 12
and at 1 year.
Background summary
Our Western lifestyle plays a large role in the onset and progression of
diabetes-2 (Lim 2011). Insulin resistance has an important role in creating a
vicious circle, where medication needs generally increase over time. Moreover,
increasing blood glucose and insulin levels speed up the processes of weight
gain, insulin resistance, inflammation, aging and comorbidity (like CVD, kidney
failure , cancers, neuropathy and dementia) (Hotamisligl 2010). Hence, reducing
insulin dependence and insulin resistance can be seen as an important
therapeutic goal. This can be achieved with healthy lifestyle improvements.
Several lifestyle interventions have created improved outcomes in type 2
diabetes patients on insulin therapy, most notably: lower blood sugar and lower
medication needs (Jenkins 2008; Esposito 2009). However, these are often highly
controlled interventions and the long term sustainability of behaviors is
limited. The question is: can we do this on a more *Do-It-Yourself* and
eSupported basis? This would have two advantages. First, since behavior
improvements are implemented within patients* lives, it improves the chance of
sustained health behavior (Simons 2013). Second, it is cheaper. Since 2010 the
Health Coach Program has been used to improve lifestyle and metabolic outcomes
(including reduced insulin needs for diabetes-2 patients) via eSupport,
improved self-management and rapidly improved health behaviors (Simons 2010,
Simons 2012). The intervention combines improving health literacy with active
behavior change support.
A personalized diagnosis (i.e. pinpointing the exact physiological problem) can
help increasing the patients* understanding of his or her medical condition and
the appropriate way to improve it, which is likely to promote adherence to
instructions. Several organs can contribute to disruption of (glucose)
metabolism in diabetes type 2 (DeFronzo 2009). Functioning of the three main
organs, pancreas, muscle tissue and liver, can be assessed by measuring glucose
and insulin at 30 min intervals during an oral glucose tolerance test (OGTT)
(Abdul-Ghani 2006). Thus, lifestyle improvement can be personalized, depending
on organ specific dysfunction, delaying or even reversing diabetes progression
(Lim 2011).
Obesity and type 2 diabetes are marked by ectopic fat accumulation in numerous
tissues, e.g. liver and heart, which profoundly impacts on tissue function. In
fact, a pile of evidence indicates that excess liver fat drives systemic
inflammation, insulin resistance and hyperglycemia, and fatty acids in heart
muscle are at the root of diabetic cardiomyopathy. Novel imaging techniques can
accurately and non-invasively quantify tissue triglyceride content and heart
function in vivo.
Study objective
1. to determine the feasibility and acceptability of an e-supported lifestyle
coaching program and
2. to assess the effects of personalized lifestyle support in patients with
insulin dependent type 2 diabetes mellitus immediately after 12 weeks and after
one year of follow up on:
• Fasting glucose levels, glucose tolerance and medication needs (insulin,
metformin)
• Pancreas, muscle and liver function as reflected by OGTT based
multi-parameter diagnosis
• Quality of life
• Progression/regression of kidney failure
• Liver, pancreas, skeletal muscle, kidney and heart ectopic fat accumulation,
and cardiovascular function
Study design
Non-randomized, one arm, pilot 12-week intervention study, with additional
effect measurement at 1 year of follow up.
Intervention
An extensive eSupported lifestyle program is offered, which combines coach
sessions with electronic dashboarding and self-management, plus electronic
health tips and a digital health quiz game. Intensive coaching is offered for 4
weeks with the purpose of generating self-propelling behaviors and
capabilities. The support in weeks 5-12 is more lightweight, with group session
at the end of weeks 6, 8 and 12, weekly electronic tips and a digital health
game.
As an umbrella overarching the personalized modifications outlined above, the
general lifestyle advice follows the guidelines of the Harvard Epidemiology and
Nutrition Group for nutrition and physical activity, with specific
modifications for diabetics. The guidelines are to increase intake of
vegetables and low sugar fruits (each 2,5 servings/day or more), to choose
whole grains instead of refined grains, to limit sugar and other high glycemic
load foods, to have one daily serving of nuts and/or legumes, to limit intake
of red meat and processed meat, to limit intake of trans and animal fats, and
to have no more than 2 (male) or 1 (female) alcoholic beverages/day. Physical
exercise guidelines are: at least 60 min/day moderate intensity activity (like
walking or gardening) and at least 3x30 min/week intensive activity (Borg level
12-14). Stress management guidelines are: relaxation exercises for >10 min/day.
Study burden and risks
Supervision of Diabetes Mellitus Type 2 patients in changing the lifestyle is
the most important part of the standard therapy. This study thus is within the
scope of the standard clinical care for the treatment of type 2 Diabetes
Mellitus. The risk associated with participation is limited to the chance of
incidental findings on MRI scan and the risk of lower blood sugars during the
diet and exercise intervention. This risk is minimized by strict glycemic
control, and where necessary, adaptation of the medication. The benefits of
improved glycemic control outweigh the low risk of hypoglycemic events in the
long term .
Successful lifestyle change provides health benefits , lower medication
requirement. Lifestyle change is difficult to adhere to, so that intensive
supervision is needed in order to be successful.
Albinusdreef 2
Leiden 2333ZA
NL
Albinusdreef 2
Leiden 2333ZA
NL
Listed location countries
Age
Inclusion criteria
Insulin-dependent Type 2 Diabetes Mellitus patients. The goal is to include at least 6 of the 12 patients with kidney damage, with eGFR < 60 ml/min/1,73m2 (CKD-EPI) and/or albumin/creatinin ratio > 2,5 mg/mmol (men) or 3,5 mg/mmol (women).
Exclusion criteria
• Recent (< 3 months) myocardial infarction
• Uncontrolled blood pressure (SBP > 170 mmHg and/or DBP > 100 mmHg, 2 out of 3 measurements)
• Any chronic disease other than type 2 diabetes hampering participation (at the discretion of the investigator)
• Low motivation to participate (score 2 *weak* or 1 *very weak* on a 5-point scale).
• Alcohol consumption of more than 28 units per week at present or in the past
• Psychiatric disease (as defined by DSM-V)
• Claustrophobia, metal implants or other contraindications for cardiac MRI
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL53321.058.15 |